Testing effectiveness (Phase 2)Study completedNCT01122030
What this trial is testing
Study to Evaluate the Safety and Efficacy of Naldemedine (S-297995) for the Treatment of Opioid-Induced Bowel Dysfunction in Subjects With Chronic Pain
Who this might be right for
Opioid Induced Bowel Dysfunction
Shionogi 72